4 Geographic Atrophy Clinical Trials in Hinsdale, IL (2026)

Q: How do I join a clinical trial in Hinsdale?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Hinsdale research site will contact you.

Recruiting Geographic Atrophy Studies in Hinsdale

NCT04557462Recruiting

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

The purpose of this study is to evaluate the long-term safety and tolerability, of open label iptacopan in primary IgA nephropathy participants who have completed either the CLNP023X2203 or CLNP023A23...

Hinsdale, ILPHASE3540 participantsNovartis Pharmaceuticals

View Study Details

NCT07043400Recruiting

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

This study is designed to assess the levels of drug exposure following treatment with tislelizumab administered as a subcutaneous (SC) injection compared to intravenous infusion (IV) as first-line the...

Hinsdale, ILPHASE3351 participantsBeiGene

View Study Details

NCT06321536Recruiting

Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)

REACT is a phase two, open-label, randomized, controlled trial of microbiota therapy (MT) to reduce colonization with multi-drug resistant organisms (MDRO). REACT is designed to assess the safety and ...

Hinsdale, ILPHASE260 participantsEmory University

View Study Details

NCT07054684Recruiting

Study of BHV-1400 in IgA Nephropathy

The purpose of this study is to determine if BHV-1400 is a safe and tolerable treatment in participants with IgA Nephropathy (IgAN)....

Hinsdale, ILPHASE120 participantsBiohaven Therapeutics Ltd.

View Study Details

About Geographic Atrophy Clinical Trials in Hinsdale

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 4 geographic atrophy clinical trials recruiting participants in Hinsdale, IL. These studies are seeking a combined 971 participants. Research is being sponsored by Novartis Pharmaceuticals, BeiGene, Emory University and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Hinsdale — FAQ

Are there geographic atrophy clinical trials in Hinsdale?

Yes, there are 4 geographic atrophy clinical trials currently recruiting in Hinsdale, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Hinsdale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hinsdale research site will contact you about next steps.

Are clinical trials in Hinsdale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hinsdale studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 4 active trials in Hinsdale are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated October 21, 2026 from ClinicalTrials.gov